H. Lee Moffitt Cancer Center & Research Institute Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
55
About the Report
About the Report
Summary
H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider. It is engaged in the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such as surgical care, fertility preservation, radiation therapy, interventional radiology, rehabilitation services, chemotherapy, cardio-oncology, blood and bone marrow transplant, cancer survivorship clinic, tumor board, interventional pain management, supportive care medicine, survivorship program, clinical trials, and others. It treats various types of cancers such as anal cancer, bladder cancer, brain cancer, breast cancer, colorectal cancer, esophageal cancer, gallbladder cancer and gastrointestinal carcinoid tumor, among others. Moffitt is headquartered in Tampa, Florida, the US.
H. Lee Moffitt Cancer Center & Research Institute Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
H. Lee Moffitt Cancer Center & Research Institute Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
H. Lee Moffitt Cancer Center & Research Institute Inc, Medical Devices Deals, 2012 to YTD 2018 10
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deal Details 14
Partnerships 14
MultiVir Enters into Licensing Agreement with Moffitt Cancer Center 14
Atara Biotherapeutics and Moffitt Cancer Center Enter into Agreement 15
Certainty Therapeutics Enters into Agreement with Moffitt Cancer Center 16
Helix BioPharma and Moffitt Cancer Center Enter into Agreement 17
Vycellix Enters into Research Agreement with Moffitt Cancer Center 18
Lion Biotechnologies Enters into Research Agreement with H. Lee Moffitt Cancer Center and Research Institute 19
Incyte Enters into Agreement with Moffitt Cancer Center 20
Morphogenesis Enters into Agreement with Moffitt Cancer Center 21
Ignyta Enters into Research Agreement with Moffitt Cancer Center 22
HealthMyne Enters into Research Agreement with Moffitt Cancer Center 23
Lion Biotech Enters into Research Agreement with Lee Moffitt Cancer Center and Research Institute 24
Rosetta Genomics Enters into Co-Development Agreement with Moffitt Cancer Center 25
Moffitt Cancer Center Enters Into Agreement With Advinus For Target Cancer Therapies 26
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 27
Licensing Agreements 29
Moffitt Cancer Center Enters into Licensing Agreement with Lixte Biotechnology 29
Aptorum Therapeutics Enters into Licensing Agreement with PolyU Technology and Consultancy, McGill University, Wayne State University, Moffitt Cancer Center and CUHK 30
Moffitt Cancer Center Enters into Licensing Agreement with Celgene 32
Lion Biotech Enters into Licensing Agreement wih Moffitt Cancer Center 33
Moffitt Cancer Center Enters into Option for Licensing Agreement with Forma Therapeutics 34
Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 35
H. Lee Moffitt Cancer Center & Research Institute Inc-Key Competitors 37
H. Lee Moffitt Cancer Center & Research Institute Inc-Key Employees 38
H. Lee Moffitt Cancer Center & Research Institute Inc-Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Recent Developments 41
Government and Public Interest 41
Jul 18, 2018: New studies show daily Aspirin use reduces ovarian cancer risk and improves survival after diagnosis 41
Jul 09, 2018: Moffitt Cancer Center Researcher Receives USD 200,000 Grant to Investigate Pancreatic Cancer 43
Jun 26, 2018: Pancreatic Cancer Action Network Funds Innovative Scientists through Research Grants Program 44
Mar 27, 2018: Screening High-Risk Individuals Can Reduce Multiple Myeloma Mortality 45
Mar 13, 2018: Moffitt researchers use single-cell imaging & math models to find effect drug properties 46
Mar 13, 2018: Moffitt Researchers Use Single-Cell Imaging and Mathematical Modeling to Determine Effective Drug Properties 47
Jun 12, 2017: Moffitt researchers identify inhibitor that overcomes drug resistance in prostate cancer 48
Jan 11, 2017: Moffitt researchers develop novel treatment to prevent graft-versus-host-disease 49
Product News 50
Oct 12, 2017: 10 SU2C Catalyst Clinical Trials Launched 50
Other Significant Developments 52
Aug 17, 2018: Moffitt Cancer Center and ITUS announce scheduling of Pre-IND Meeting with the FDA for their CAR-T therapy 52
Mar 27, 2018: Moffitt Is Only Cancer Center In Florida Named 2018 LGBTQ Healthcare Equality Leader 53
Jan 18, 2018: Lung Cancer Patients to Help Medical Community Understand the Side Effects of Immunotherapy Treatment 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
List of Figure
List of Figures
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
H. Lee Moffitt Cancer Center & Research Institute Inc, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Key Facts 2
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
H. Lee Moffitt Cancer Center & Research Institute Inc, Deals By Therapy Area, 2012 to YTD 2018 9
H. Lee Moffitt Cancer Center & Research Institute Inc, Medical Devices Deals, 2012 to YTD 2018 10
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
MultiVir Enters into Licensing Agreement with Moffitt Cancer Center 14
Atara Biotherapeutics and Moffitt Cancer Center Enter into Agreement 15
Certainty Therapeutics Enters into Agreement with Moffitt Cancer Center 16
Helix BioPharma and Moffitt Cancer Center Enter into Agreement 17
Vycellix Enters into Research Agreement with Moffitt Cancer Center 18
Lion Biotechnologies Enters into Research Agreement with H. Lee Moffitt Cancer Center and Research Institute 19
Incyte Enters into Agreement with Moffitt Cancer Center 20
Morphogenesis Enters into Agreement with Moffitt Cancer Center 21
Ignyta Enters into Research Agreement with Moffitt Cancer Center 22
HealthMyne Enters into Research Agreement with Moffitt Cancer Center 23
Lion Biotech Enters into Research Agreement with Lee Moffitt Cancer Center and Research Institute 24
Rosetta Genomics Enters into Co-Development Agreement with Moffitt Cancer Center 25
Moffitt Cancer Center Enters Into Agreement With Advinus For Target Cancer Therapies 26
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 27
Moffitt Cancer Center Enters into Licensing Agreement with Lixte Biotechnology 29
Aptorum Therapeutics Enters into Licensing Agreement with PolyU Technology and Consultancy, McGill University, Wayne State University, Moffitt Cancer Center and CUHK 30
Moffitt Cancer Center Enters into Licensing Agreement with Celgene 32
Lion Biotech Enters into Licensing Agreement wih Moffitt Cancer Center 33
Moffitt Cancer Center Enters into Option for Licensing Agreement with Forma Therapeutics 34
Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 35
H. Lee Moffitt Cancer Center & Research Institute Inc, Key Competitors 37
H. Lee Moffitt Cancer Center & Research Institute Inc, Key Employees 38
H. Lee Moffitt Cancer Center & Research Institute Inc, Subsidiaries 40
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.